Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2006-01-03
2006-01-03
Canella, Karen A. (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S006120, C435S007400, C436S063000, C436S071000, C436S503000
Reexamination Certificate
active
06982142
ABSTRACT:
Methods of detecting novel therapeutically active compositions based on their ability to modulate the glycolipid metabolism and overcome multidrug resistance are described. These methods are particularly useful in screening for novel chemotherapeutic agents for the treatment of cancer, as well as chemosensitizers that are capable of enhancing the cytotoxicity of such chemotherapeutic agents. A combination of one or more of these compositions can be used in the treatment of a various cancers.
REFERENCES:
patent: 5677337 (1997-10-01), Wei et al.
patent: 5677341 (1997-10-01), Lyons
patent: 5885786 (1999-03-01), Cabot
patent: WO 95/21175 (1995-08-01), None
patent: WO 97/10817 (1997-03-01), None
patent: WO 97/40358 (1997-10-01), None
patent: WO 99/07855 (1999-02-01), None
patent: WO/99/28747 (1999-06-01), None
Mestdagh et al, “Comparative study of intracellular calcium and adenosine 3′, 5′-cyclic monophosphate levels in human breast carcinoma cells sensistive or resistant to adriamycin”, Biochemical Pharmacology, 1994, vol. 48, pp. 709-716.
de Chaves et al, “Elevation of Ceramide within Distal Neurites Inhibits Neurite Growth in Cultured Rat Sympathetic Neurons”, Journal of Biological Chemistry, vol. 272, No. 5, pp. 3028-3035, Jan. 1997.
Lavie et al, “Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells”, Journal of Biological Chemistry, vol. 271, No. 32, pp. 19530-19536, Aug. 1996.
Abe et al., “Metabolic Effects of Short—Chain Ceramide and Glucosylceramide on Sphingolipids and Protein Kinase C,”Eur. J. Biochem., 210:765-773 (1992).
Abe et al., “Structural and Stereochemical Studies of Potent Inhibitors of Glucosylceramide Synthase and Tumor Cell Growth,”Journal of Lipid Research, 36:611-621 (1995).
Bose, R. et al., “Cermide Synthase Mediates Daunorubicin-Induced Apoptosis: An Alternative Mechanism for Generating Death Signals”Cell82:405-414 (1995).
Breimer et al., “The Specific Glycosphingolipid Composition of Human Ureteral Epithelial Cells”,J. Biochem., 98(5):1169-1180 (1985).
Cabot et al., “Tamoxifen Retards Glycosphingolipid Metabolism in Human Cancer Cells”,FEBS Letters394:129-131 (Oct. 1, 1996).
Cabot, M.C. et al., “Apoptosis—A Cell Mechanism Importatn for Cytoxic Response to Adriamycin and a Lipid Metabolic Pathway That Facilitates Escape”,Breast Cancer Resistance Treatment, vol. 46(1):Abstract 283, p. 71 (1997).
Cai, Z. et al., “Alteration of the Sphingomyelin/Ceramide Pathway is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-α- Mediated Cytotoxicity”The Journal of Biological Chemistry, 272:6918-6926 (1997).
Callaghan and Higgins, “Interaction of Tamoxifen with the Multidrug Resistance P-Glycoprotein,”British Journal of Cancer, 71:294-299 (1995).
Chatterjee and Harris, “Reversal of Acquired Resistance to Adriamycin in CHO Cells by Tamoxifen and 4—Hydroxy Tamoxifen: Role of Drug Interaction with Alpha 1 Acid Glycoprotein,”Br. J. Cancer, 62:712-717 (1990).
Cheresh et al., “Localization of the Gangliosides GD2, and GD3, in Adhesion Plaques and on the Surface of Human Melanoma Cells,”Proc. Nat'L Acad. Sci. USA, 81:5767-5771 (Sep., 1984).
Chuma, S. J. et al., “Loss of Ceramide Production Confers Resistance to Radiation-induced Apoptosis,”Cancer Research57:1270-1275 (1997).
Dyatlovitskaya et al., “Sphingolipids and Malignant Growth”Biochemistry(Moscow) 60(6): 629-633 (Jun. 1995).
Escriba et al., “Role of Membrane Lipids on the Interaction of Daunomycin with Plasma Membranes from Tumor Cells: Implications in Drug-Resistance Phenomena,”Biochemistry, 29:7275-7282 (1990).
Ford et al., “Structural Features Determining Activity of Phenothiazines and Related Drugs for Inhibition of Cell Growth and Reversal of Multidrug Resistance,”Molecular Pharmacology, 35:105-115 (1988).
Hannun, Y. et al., “The Sphingomyelin Cycle and the Second Messenger Function of Ceramide”,The Journal of Biological Chemistry269:3125-3128 (1994).
Hannun and Obeid., “Ceramide: an Intracellular Signal for Apoptosis”,Trends Biochemical Science20:73-77 (1995).
Holleran et al., “Characterization of Cellular Lipids in Doxorubicin-Sensitive and -Resistant P388 Mouse Leukemia Cells”Cancer Chemotherapy and Pharmacology17(1):11-15 (May 1986).
Ikushima et al., “Effects of Polyunsaturated Fatty Acids on Vincristine-Resistance in Human Neuroblastoma Cells,”AntiCancer Research, 11:1215-1220 (1991).
Inokuchi et al., “Effects of D-Threo-PDMP, an Inhibitor of Glucosylceramide Synthetase, on Expression of Cell Surface Glycolipid Antigen and Binding to Adhesive Proteins by B16 Melanoma Cells,”Journal of Cellular Physiology, 141:573-583 (1989).
Inokuchi et al., “Antitumor Activity Via Inhibition of Glycoshingolipid Biosynthesis”Cancer Letters38:23-30 (Dec. 1987).
Inokuchi and Radin, “Preparation of the Active Isomer of 1-Phenyl-2-Decanoylamino-3-Morpholino-1-Propanol, Inhibitor of Murine Glucocerebroside Synthetase,”Journal of Lipid Research, 28:565-571 (1987).
Jaffreézou et al., “Inhibition of Lysosomal Acid Sphingomyelinaseby Agents Which Reverse Multidrug Resistance,”Biochimica et Biophysica Acta1266:1-8 (1995).
Jarvis, W. D. et al., “Ceramide and the Induction of Apoptosis”,Clin. Cancer Research2:1-6 (1996).
Kajiji et al., “Structurally Distinct MDR Modulators Show Specific Patterns of Reversal Against P-Glycoproteins Bearing Unique Mutations at Serine,”Biochemistry, 33(17):5041-5048 (1994).
Kirk et al., “Reversal of P—Glycoprotein—Mediated Multidrug Resistance By Pure Anti-Oestrogens and Novel Tamoxifen Derivatives,”Biochemical Pharmacology, 48(2):277-285 (1994).
Kolesnick and Golde., “The Sphingomyelin Pathway in Tumor Necrosis Factor and Interleukin-1 Signaling”,Cell77:325-328 (1994).
Lavie et al., “Accumulation of Novel Sphingoid Bases in Multidrug-Resistant (MDR) Human Breast Cancer MCF-7 Cells”Proc. Annu. Meet. Am. Assoc. Cancer Inst.37:A2247:XP-002100453 (1996).
Lavie et al., “Agents that Reverse Multidrug Resistance, Tamoxifen, Verapamil and Cyclosporin A, Block Glycosphingolipid Metabolism by Inhibiting Ceramide Glycosylation in Human Cancer Cells”The Journal of Biological Chemistry272(3):1682-1687 (Jan. 17, 1997).
Lavie et al., “Accumulation of Glucosylceramides in Multidrug-resistant Cancer Cells”,The Journal of Biological Chemistry271:19530-19536 (1997).
Le Moyec et al., “Proton Nuclear Magnetic Resonance Spectroscopy Reveals Cellular Lipids Involved in Resistance to Adriamycin and Taxol by the K562 Leukemia Cell Line,”Cancer Research, 56:3461-3467 (1996).
Lloyd et al., “Cell Surface Accessibility of Individual Gangliosides in Malignant Melanoma Cells to Antibodies Is Influenced by the Total Ganglioside Composition of the Cells,”Cancer Research, 52:4948-4953 (Sep. 1992).
Lucci, A. et al., “Glucosylceraminde: a Marker for Multiple-Drug Resistant Cancers”,Anticancer ResearchJan.-Feb.; 18(1B) 475-480 (1998).
Madhavi and Das, “Effect of n-6 and n-3 Fatty Acids on the Survival of Vincristine Sensitive and Resistant Human Cervical Carcinoma Cells In Vitro,”Cancer Letters, 84:31-41 (1994).
McKibbin et al, “Glycosphingolipids of Cultured Human Colon Carcinoma Cells and Their Drug-Resistant Sublines”,Biochimica et Biophysica Acta, 958:235-246, 1988.
Michael, J. M. et al., “Resistance to Radiation-Induced Apoptosis in Burkitt's Lymphona Cells is Associated with Defective Ceramide Signaling”,Cancer Research57:3600-3605 (1997).
Nakamura, S. et al., “Dual Roles of Sphinoglipids in Signaling of the Escape from and Onset of Apoptosis in a Mouse Cytotoxic T-cell Line, CTLL-2”,The
Canella Karen A.
Hogan & Hartson LLP
John Wayne Cancer Institute
LandOfFree
Methods for screening therapeutically effective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for screening therapeutically effective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for screening therapeutically effective agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3596018